Central Apnea in Patients Receiving Ticagrelor

NCT03540459 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2020-02-07

No results posted yet for this study

Summary

all patients with a left ventricular ejection fraction superior or equal to 50% less than 2 years after an acute coronary event and receiving ticagrelor will undergo a sleep polygraphy

Conditions

  • Acute Coronary Syndrome

Interventions

DIAGNOSTIC_TEST

sleep polygraphy

sleep polygraphy (one night) in all included patients

Sponsors & Collaborators

  • Les Grands Prés

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-01
Primary Completion
2020-09-01
Completion
2020-09-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03540459 on ClinicalTrials.gov